Martin Barkin

Martin Barkin

Geen lopende functies

87 jaar
Health Technology
Commercial Services
Health Services

Profiel

Martin Barkin served as President & CEO of Deprenyl Research Ltd.
from 1993 to 2007.
He was also the CEO of Sunnybrook Health Sciences Centre in 1987 and Chairman of CareRx Corp.
from 2008 to 2010.
Barkin held various other director and chairman positions in companies such as Blue-Zone Technologies Ltd., Bone Care International, Inc., and Viventia Biotech, Inc. He was also a Professor at the University of Toronto and Head of Health Care Consulting at KPMG LLP (Canada).
Barkin received his doctorate degree from the University of Toronto in 1960, followed by an undergraduate degree in 1962 and a graduate degree in 1963.

Eerdere bekende functies van Martin Barkin

BedrijvenFunctieEinde
Directeur/Bestuurslid 22-01-2018
NORTHWEST HEALTHCARE PROPERTIES REAL ESTATE INVESTMENT TRUST Directeur/Bestuurslid 22-01-2018
Voorzitter 22-01-2018
Directeur/Bestuurslid 22-01-2018
Directeur/Bestuurslid 22-01-2018
Ervaring van Martin Barkin in detail bekijken

Opleiding van Martin Barkin

University of Toronto Doctorate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Martin Barkin in detail bekijken

Connecties

100 +

Eerstegraads connecties

16

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven3
ALLON THERAPEUTICS INC.

Health Technology

CARERX CORPORATION

Health Services

NORTHWEST HEALTHCARE PROPERTIES REAL ESTATE INVESTMENT TRUST

Finance

Bedrijven in privébezit12

Health Technology

Health Services

Health Technology

Sunnybrook & Women’s College Health Science Centre

Commercial Services

Commercial Services

Commercial Services

Health Technology

Commercial Services

Health Technology

Health Services

Health Technology

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Martin Barkin
-40 % Aanbod van beperkte duur: onze abonnementen leiden je naar de beste beleggingen van morgen.
PROFITEER NU